ERBB2 and breast cancer: An increased TIL concentration is a beneficial prognostic marker for human epidermal growth factor receptor 2 (HER2)-positive breast cancer and TNBC (triple-negative breast cancer), but is unfavorable for luminal HER2-negative breast cancer [42].